PP
TNDM icon

PrairieView Partners’s Tandem Diabetes Care TNDM Stock Holding History

PrairieView Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$20K – 317
2020
Q2 		$20K Hold
200
– – ﹤0.01% 193
2020
Q1 		$13K Buy
+200
New +$14K ﹤0.01% 207

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PrairieView Partners's TNDM Position: Q3 2020 in Review

PrairieView Partners sold out of Tandem Diabetes Care (TNDM) in Q3 2020, closing a stake of 200 shares — an estimated $20K sold.

PrairieView Partners first reported a position in TNDM in Q1 2020 and held it in 2 quarters. The position peaked at $20K in Q2 2020. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

  • PrairieView Partners reported no remaining Tandem Diabetes Care position as of Q3 2020 after selling out during the quarter.
  • PrairieView Partners sold 200 Tandem Diabetes Care shares in Q3 2020, an estimated $20K.
  • PrairieView Partners first reported a position in Tandem Diabetes Care in Q1 2020 and held it in 2 quarters.
  • PrairieView Partners's Tandem Diabetes Care position peaked at $20K in Q2 2020.
  • 321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on PrairieView Partners's 13F filing for Q3 2020, filed 30 Oct 2020.